ARCHIVES

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

This article is from The Cancer Letter archive.

Vol. 04 No. 10 | March 10, 1978

Download PDF Visit The Full Archive

Related Articles

FDA News: Agency Accepting Nominations For Patient Representatives

May 8, 1998

Brinker Again To Lead Komen As CEO

December 11, 2009

NIH appoints panel to review conflict of interest rules.

February 27, 2004

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

Bepler To Lead Karmanos Cancer Institute

January 29, 2010

Senior Biomedical Service Proposed To Increase Pay

April 1, 1988